![Tassos Gianakakos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 145 M $ al 30/09/2026
En la actualidad, Anastasios E. Gianakakos ocupa el cargo de Director General de MyoKardia, Inc. También forma parte del consejo de administración de LianBio. En el pasado, el Sr. Gianakakos fue presidente y vicepresidente senior de desarrollo empresarial en Codexis, Inc., ingeniero de procesos en Merck & Co., Inc., director de desarrollo empresarial en Maxygen, Inc. y director empresarial y vicepresidente senior en MAP Pharmaceuticals LLC. Se licenció en el Massachusetts Institute of Technology, se graduó en la Northwestern University y obtuvo un MBA en la Harvard Business School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
10,49 % | 30/06/2026 | 9.806.633 ( 10,49 % ) | 145 M $ | 30/09/2026 |
LIANBIO 0,35 % | 15/02/2024 | 363.253 ( 0,35 % ) | 14 893 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Prolaio, Inc.
 Prolaio, Inc. Packaged SoftwareTechnology Services Operates as a patient-centered clinical intelligence company | Fundador | 01/11/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| LIANMEDICAL | Director/Miembro de la Junta | 01/03/2024 |
| MYOKARDIA, INC. | Director Ejecutivo | 01/11/2020 |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Corporate Officer/Principal | 01/03/2013 |
| MERCK & CO., INC. | Director Técnico/Científico/I+D | 01/01/1997 |
| CODEXIS, INC. | Presidente | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Commercial Services |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LianBio
 LianBio BiotechnologyHealth Technology Operates as a biotechnology company focused on bringing paradigm-shifting medicines to patients | Health Technology |
Prolaio, Inc.
Prolaio, Inc. Packaged SoftwareTechnology Services Operates as a patient-centered clinical intelligence company | Technology Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
